Alpha fetoprotein (AFP) is synthesized by the x human fetal liver and yolk sac [8, 9] . During the 12 th -14 th intrauterine weeks the serum concentration of AFP is at its highest, reaching a few milligrams per ml [7] . However, the total amount of AFP in the fetus increases until the 22 nd week of gestation, remaining constant until about the 32 nd week, and thereafter decreasing [7] . In the newborn at term, the serum AFP concentration is 50-ISO^g per ml [19] . AFP remains detectable by immunodiffusion or related methods for about 5 weeks after birth [24] . Greatly increased serum AFP levels cften reappear in adults with primary hepatocellular cancer [25] or teratocarcinomas [1] . Until recently, the occurrence of AFP in maternal serum had been contested [3] . We purified immunochemically human AFP [14] and developed a radioimmunoassay (RIA) for its determination [15] . It became evident thät small amounts (2-16 ng per ml) of AFP are present in normal human serum [15, 16] . This finding has now been confirmed by other groups [6, 13] . AFP levels in maternal serum increase during pregnancy and the highest AFP concentrations occur during the third trimester. The half life of maternal serum AFP after delivery is about 5 days [19] . In amniotic fluid, the AFP concentrations decrease from the 15 th week of gestation, and at term the concentrations are similar to those in maternal serum [19, 21] . Recently, we found that the maternal serum AFP concentration often increases in asso- 1963 -1965 . Resident at Dept. of Obstetrics and Gynecology., University Central Hospital, Helsinki 1966-1969. Senior lecturer in Obstetrics and Gynecology, 1970. Assistant professor at Dept. II of Obstetrics and Gynecology (Head: Professor PAAVO VARAJ, University Central Hospital, Helsinki, 1970.'* ciation with fetal death [20] , and that this increase may occur even before the fetal death [23] . In the present paper we describe results on the AFP concentrations in normal and pathological pregnancies, and evaluate the clinical significance of the serum AFP levels in the antenatal diagnosis of high risk pregnancies.
Amniotic fluid samples
Amniotic fluid specimens were collected from 55 normal pregnancies. Fifty-three specimens were collected through an amnioscope by rupturing the fetal membranes, and 2 samples by puncture through the abdominal wall. Eight specimens from 4 high risk pregnancies with severe fetoplacental dysfunction (3 diabetic patients and l with hydramnion and fetal meningomyelocele) were obtained through abdominal taps. Samples contaminated with red blood were discarded.
Homologous antibodies to AFP
Sera from 10 normal and 10 toxemic pregnancies were collected A-19 weeks after delivery for the study of AFP antibodies. Serum samples from a further case where twins died in utero were also studied 3-7 weeks after the delivery (Fig.6 ).
Methods 2.1 Radioimmunoassay of AFP
AFP was measured by the double antibody radioimmunoassay, äs described previously [15] . Serum and amniotic fluid samples were usually assayed at dilutions of 1:25 or higher.
AFP in the early human conceptus
After curettage of a 4-week-old pregnancy, the uterine contents were homogenized in an equal volume (2.5 ml) of saline by teasing them several times through a No. 16 injection needle. After centrifugation, the supernatant and the corresponding maternal serum were examined for AFP in RIA.
Search for homologous AFP antibodies
The test sera were incubated with 125 I-AFP, after which the precipitation was performed by adding anti-human gamma globulin serum prepared in rabbits. The presence of human antibodies to AFP in the test sera would increase the radioactivity of the precipitate under the test conditions.
Assessment of the predictive efficacy of the AFP test in fetoplacental dysfunction
The normal ränge was calculated by determining the 95% tolerance limits for the AFP concentrations in 204 normal pregnancies [10] . AFP concentrations above or below this ränge were considered abnormal. Severe fetoplacental dysfunction was assumed when two or more of the following signs were present [23] : abnormal fetal heart action (late deceleration or Variation greater than 110-170 beats per min), fetal acidosis below pH 7.25, meconium in amniotic fluid, retarded intrauterine growth, and intrauterine fetal death. The occurrence of severe fetoplacental dysfunction in the group with normal AFP levels was compared with the group with abnormal AFP concentrations. Clinical decisions were not governed by the AFP concentrations.
Results

AFP in the early human conceptus
The supernatant of the uterine contents obtained by curettage contained 325 ng o£ AFP in a volume of 2.5 ml, while the corresponding maternal serum AFP concentration was 24 ng per ml.
Ninety-five per cent tolerance limits for
the AFP concentrations The maternal serum AFP concentration increased from the 8 th week of pregnancy. Between 8 and 12 weeks, about one half of the values were above the upper non-pregnant level (16 ng per ml). The 95% tolerance limits for the AFP concentrations äs a function of duration of pregnancy are given in Fig. 1 . The highest AFP concentrations occurred between 28 and 36 weeks of gestation, where the upper AFP level was about 500 ng per ml.
Maternal serum AFP concentrations in diabetic pregnancies
Of the 67 serum samples from 20 diabetic patients, the highest individual AFP concentrations exceeded the normal ränge in 4 cases (20%) (Fig. 2) . Fetal distress was present in all of these patients, while distress was found in only 4 of the 16 women (25%) whose AFP concentrations were within the normal ränge. 
Maternal serum AFP concentrations in
patients with toxemia or hypertension Abnormal serum AFP concentrations were present in 14 o£ the 74 patients (19%) with toxemia or hypertension (Fig. 3) . Severe fetoplacental dysfunction was found in 7 patients with abnormal AFP concentrations (50%) and in 4 of the 56 women (7%) with normal AFP levels.
pregnant women with a liver disorder Four o£ the 27 patients (15%) with a liver disorder had abnormal serum AFP concentrations (Fig. 4) . Severe fetoplacental dysfunction was associated with 2 of these (50%), and with 3 of the 23 patients with normal AFP levels (13%). 
Intrauterine fetal death
The serum AFP concentrations in the 22 women whose fetus died in utero were abnormal in 15 patients (68%): the concentrations increased in 14 women and were abnormally low in one patient at the time of fetal death (Fig. 5) . In a case where twins died in utero during the 26 th week of gestation, the AFP concentrations remained above the upper normal pregnancy level for 10 days after delivery (Fig. 6) , and the estimated half life of AFP was 4.2 days in this case. Out of the 4 cases where the AFP concentrations were measured before the intrauterine fetal death occurred, increased levels were found in 3 ( Fig. 5 ).
Assessment of severe fetoplacental dys-
function by the AFP test The compiled data from Figs. 2 to 5 indicate that abnormal serum AFP concentrations were associated with severe fetoplacental dysfunction in 59% of the cases, while normal AFP levels coincided with fetal distress in only 11% (Tab. I). The difference is highly significant (p < 0.001). patients, all of whom were diagnosed äs having severe fetoplacental dysfunction ( Fig. 8 a-c) . Polyhydramnion was present in one patient with an amniotic fluid AFP concentration of 400 ng per ml at the 26 th week of gestation. The fetus was alive at that time, but died in utero a week later. The AFP concentration at this time was 48000 ng per ml (Fig. 8d) . The fetus appeared to have meningomyelocele.
Homologous AFP antibodies
Serum samples from 10 normal and 11 pathologic pregnancies did not bind labeled 125 I-AFP at any time (3-19 weeks) after delivery. The result shows that there were no homologous circulating antibodies to AFP that could be demonstrated with the radioimmunoassay employed.
Discussion
. f 4.1 The source of AFP Alpha fetoprotein was present at a higher concentration in the products of conception than in the maternal serum, which suggests that AFP is being synthesized at an early stage (4 weeks) of pregnancy by the human conceptus.
Increased maternal AFP levels
Abnormally high circulating maternal AFP concentrations were most frequently seen in women whose fetuses died in utero. However, moderate elevations above the normal pregnancy ränge were also found in women with severe fetoplacental dysfunction. We assume that the increased maternal AFP originates from the fetus in these conditions, although increased maternal AFP concentrations could be anticipated under circumstances in which the maternal liver is affected. This has been observed in some non-neoplastic liver diseases [2, 17] . The increased fetal AFP in the maternal circulation may result from an increased fetal AFP concentration, increased transplacental passage of fetal blood, or transmission of fetal elements from the amniotic fluid to the mother. While all these mechanisms may be operating, there is preliminary evidence indicating that distressed newborn infants have higher AFP concentrations than normal infants of similar gestational ages [12] .
Low maternal AFP levels
The significance of low maternal AFP levels is not established. In one patient whose fetus died in utero during the 38 th week of gestation, the maternal serum AFP concentration was 20 ng per ml, and rose to 28 ng per ml after delivery. In the case of a fetal meningomyeloce^ (Fig. 8d ), the maternal serum AFP level was low (30 ng per ml) even at a time when the amniotic fluid AFP level had increased to 48000 ng per ml. In anöther case of severe pre-eclampsia with a distressed fetus, the maternal serum AFP concentration was only 26 ng per ml. It is possible that certain types of diseases lead to increased maternal serum AFP concentrations, while others do not.
Fetal distress and normal maternal AFP
levels While abnormal maternal serum AFP concentrations were associated with severe fetoplacental dysfunction in 59% of the cases, fetal distress occurred in 11% of the women with normal AFP levels. There were 4 women whose fetal distress was correctly indicated by the maternal serum AFP concentration, while the estriol excretion was normal. Our results suggest that the serum AFP level can increase the cumulative efficacy of the biochemical methods used f or the monitoring of high risk pregnancies. Even if used alone, high circulating maternal AFP levels are informative from the clinical point of view, since obstetrical decisions in high risk pregnancies rest largely upon the evaluation of risks associated with Intervention versus those of waiting, provided that the fetus is considered viable.
Amniotic fluid AFP levels in normal pregnancies
The AFP concentration in amniotic fluid can indicate the gestational age of the fetus in normal pregnancies. In a previous study we showed that the decreasing AFP concentrations in amniotic fluid were related to gestational age rather than to the weight of the iüfant [21] . A similar decrease occurs in fetal serum during gestation [4] . AFP concentrations smaller than 185 ng per ml in amniotic fluid indicate that pregnancy has advanced to at least the 37 th week. Our values f or amniotic fluid AFP concentrations were smaller than those reported by BROCK and SUTCLIFFE [5] , who found AFP concentrations of äs high äs 6000 ng per ml in amniotic fluid samples from the 39 th week of gestation. This disagreement can only partly be explained by the different Standards used: a pure Standard gives smaller concentrations than One less specific. The BEHRINGWERKE Standard gives values for AFP twice äs high äs ours [14] .
Amniotic fluid AFP levels in pathological pregnancies
The determination of gestational age by the amniotic fluid AFP level seems to be obscured by changes found in some pathological pregnancies. In the present series, we examined 4 cases where the AFP concentrations increased at the time when fetal distress developed; normally a decrease is observed. Increasing amniotic fluid AFP concentrations may in certain cases provide a more sensitive marker for fetal distress than maternal serum AFP concentrations. This is indicated by the smaller increase, or even a decrease in the serum AFP levels in diabetic patients with fetoplacental dysfunction, while the amniotic fluid AFP concentrations increased (Fig. 8 a-c) . We have recently found that the AFP concentrations in amniotic fluid increase in cases of severe maternal Rh-immunization or intrauterine fetal death where no gross fetal malformations are present. It is possible that the high AFP concentrations found in the control samples of BROCK and SUTCLIFFE [5] were related to Rh-immunization and, in the light of the present results, it would be interesting to know whether the remarkably high AFP concentrations found in spina bifida and anencephaly [5] were also related to fetal distress or specifically to the underlying disease. Our case of fetal meningomyelocele was associated with a normal (400 ng per ml) amniotic fluid AFP concentration during the 26 th week, but the AFP level increased to 48000 ng per ml when the fetus died in utero. In addition to fetal distress, leakage of AFP through the meningomyelocele may also have contributed to the marked increase in the amniotic fluid AFP concentration at the time of fetal death. We found a moderately increased amniotic fluid AFP level and a normal maternal serum AFP concentration in another case where the fetus died suddenly of a cord complication. It seems that the increased circulating maternal AFP concentrations reflect chronic rather than acute fetoplacental dysfunction and that the amniotic fluid AFP levels change more rapidly.
4.7
The source of amniotic fluid AFP Unlike other proteins in amniotic fluid [18, 22] , the direct source of the major portion of amniotic fluid AFP seems to be the fetal urine [21] , where the AFP concentration is higher than in amniotic fluid. This is true of early but not late pregnancy [21] . It would be interesting to know whether the AFP concentrations in newborn urine are higher in distressed than in normal infants.
Homologous AFP antibodies
The AFP concentration of 4200 ng per ml in maternal serum in a case in which twins died in utero (Fig. 6) indicates that more than 10 mg of AFP had passed to the mother. However, no human antibodies to homologous AFP were detected in this case, during pregnancy [19] , or in the postpartum sera of several other cases using the radioimmunoassay. Previous contact with high serum AFP concentrations during the embryonal period results in the recognition of AFP äs a "seif", and the low AFP concentrations in normal human serum are likely to maintain tolerance to AFP. Recently, it has been shown that rabbits produce antibodies to their homologous AFP when immunized with human AFP [11] , which suggests that antibodies to AFP may occur in humans. Radioimmunoassay is sensitive for the detection of antibodies with a relatively high affinity, and our results therefore do not exclude the existence of low affinity antibodies in the cases studied. Summary A. Alpha fetoprotein (AFP) was measured by a highly sensitive radioimmunoassay in tissue homogenate of an early human conceptus, maternal serum and amniotic fluid in normal and high risk pregnancies. Human products of conception contained more AFP than maternal serum at the 4 th week of gestation indicating that AFP is synthesized by the human conceptus at this early stage of development. B. In maternal serum, the AFP concentrations increased with advancing gestation: the highest levels -about 500 ng per ml -were present during the midthird trimester; these values were based on the AFP levels in 204 normal pregnancies (Fig. 1) . G. Circulating maternal AFP concentrations increased in cases with severe fetoplacental dysfunction. In 67 serum samples from 20 diabetic pregnancies, the AFP concentrations were above the normal ränge in 4 patients (20%). Fetal distress was present in all these cases and in 4 of the 16 women (25%) whose AFP levels were within the normal ränge (Fig. 2) . In 74 pregnant women with toxemia or hypertension, abnormal serum AFP concentrations were present in 14 (Fig. 3) . Severe fetal distress was present in 7 of these (50%) and in 4 out of the 60 women (7%) whose serum AFP concentrations were within the normal ränge. In patients with a liver disorder, 4 of 27 had abnormal serum AFP concentrations (15%). Severe fetal distress was present in 2 of these (50%) and in 3 of the 23 patients with normal AFP levels (13%) (Fig. 4) . In 22 cases of intrauterine fetal death, abnormal maternal serum AFP concentrations occurred in 15 patients (68%): the AFP levels were increased in 14 women and abnormally low in one (Fig. 5 ). There were 4 women whose serum AFP concentrations were measured before intrauterine fetal death occurred: the levels were found to be increased in three. Fetal distress was correctly indicated by abnormal maternal serum AFP concentrations in 4 cases where the estriol excretion was normal. In all, abnormal AFP concentrations in maternal serum were associated with severe fetoplacental dysfunction in 59% of the cases, while normal levels coincided with fetal distress significantly less frequently (11%) (p < 0.001, Tab. I). D. We assume that the major part of the circulating maternal AFP originales from the fetus, and that the increase above the normal pregnancy ränge of maternal serum AFP concentration can result from an increased fetal serum AFP level, increased transplacental passage of fetal blood, or transmission of fetal elements from the amniotic fluid to the mother. E. The maternal serum AFP concentrations remained above the normal pregnancy ränge for 10 days, and above the upper nonpregnant level for 30 days after delivery of macerated twins* (Fig. 6) v The estimated half-life of AFP was 4.2 days in this case. F. In normal amniotic fluid, the AFP concentrations decreased during gestation (Fig. °7) . The mean AFP levels (ng per ml) were: 316 at 35-36 weeks, 164 at 37-38 weeks, 115 at 39-40 weeks, and 87 at 41-42 weeks. Amniotic fluid AFP concentrations may indicate the gestational age of the fetus in normal pregnancies. G. In high risk pregnancies, increased AFP concentrations in amniotic fluid were associated with fetal distress. In serial amniotic fluid samples from 3 diabetic pregnancies, the AFP concentrations increased at the time when fetal distress became clinically evident (Fig. 8 a-c) . In a case of fetal meningomyelocele, the AFP concentration in amniotic fluid was normal in the first specimen, but increased markedly at the time of intrauterine fetal death (Fig. 8d) . According t o these preliminary results it seems that the AFP concentrations of both maternal serum and amniotic fluid can be useful in the assessment of fetal state in high risk pregnancies. H. A radioimmunologic method was designed to detect naturally occurring human antibodies to AFP. No antibodies could be demonstrated 3-19 weeks after normal or pathologic pregnancies. Previous contact during the embryonal period with high serum AFP con-centrations would be expected to tesult in the recognition o£ AFP äs a "seif" during the adult life, and the low AFP concentrations in normal human serum are likely to maintain tolerance to AFP so that even high circulating maternal AFP concentrations are not sufficient to elicit an immune response. . 8 a-c) . Dans un cas de myelomeningocele, la concentration amniotique d'A. F. P. etait normale dans le premier echantillon, mais a augmente tres notablement au moment de la mort foetale in utero (fig. 8d) . Selon ces premiers resultats v il semble que le taux d'A. F. P. aussi bien dans le serum maternel que dans le liquide amniotique puisse etre un element utile d'appreciation de l'etat foetal dans les grossesses a haut risque. H. Une methode radio-immunologique etait apte a detecter des anticorps naturels anti A. F. P. II n'en a pas ete trouve 3 ä 19 semaines apres des grossesses normales ou pathologiques. Un contact prealable pendant la periode embryonnaire avec de hautes concentrations seriques d'A. F. P. est susceptible d'expliquer la reconnaissance ulterieure de A. F. P. comme «non etrangere» a Tage ädulte; de plus, l'existence d'un tres faible taux serique d'A. F. P. chez l'adulte normal est susceptible de maintenir une tolerance vis a vis de . F. P. de teile maniere que meme les taux eleves chez la femme enceinte ne sont plus susceptibles d'induire une reponse immunitaire.
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